Successful treatment of pure red cell aplasia with rituximab in patients with chronic lymphocytic leukemia

Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program.

1998 • 2,777 citations

Depletion of B cells in vivo by a chimeric mouse human monoclonal antibody to CD20

1994 • 1,932 citations

Anti-CD20 monoclonal antibody for the treatment of severe, immune-mediated, pure red cell aplasia and hemolytic anemia

2001 • 173 citations

Pure red cell aplasia due to parvovirus B19 in a patient treated with rituximab

2000 • 133 citations

T gamma (T gamma) cells suppress growth of erythroid colony-forming units in vitro in the pure red cell aplasia of B-cell chronic lymphocytic leukemia.

1982 • 112 citations

Prolonged CD4 depletion after sequential autologous peripheral blood progenitor cell infusions in children and young adults

2000 • 102 citations

Pure Red-Cell Aplasia in Patients with Chronic Lymphocytic Leukemia

1986 • 74 citations

Chronic cold agglutinin disease of the “idiopathic” type is a premalignant or low‐grade malignant lymphoproliferative disease

1997 • 65 citations

Rituximab (anti-CD20 monoclonal antibody) for the treatment of patients with clonal lymphoproliferative disorders after orthotopic liver transplantation: a report of three cases

2000 • 64 citations

Evidence for reduced erythroid burst (BFUE) promoting function of T lymphocytes in the pure red cell aplasia of chronic lymphocytic leukemia.

1981 • 36 citations

Deficient APC-cofactor activity of protein S Heerlen in degradation of factor Va Leiden: a possible mechanism of synergism between thrombophilic risk factors

2000 • 36 citations

Hypoplastic anemia in B cell chronic lymphocytic leukemia: evolution of T cell-mediated suppression of erythropoiesis in early-stage and late- stage disease

1985 • 36 citations

Acquired pure red cell aplasia associated with chronic lymphocytic leukemia

1983 • 18 citations